2 Result: Biophytis
Biophytis Gains Momentum; bluebird bio Posts Mixed Results
August 08th, 2023
Shares of Biophytis S.A. (Nasdaq: BPTS) surged over 10% in pre-market trading as the company secured a favorable opinion from Belgian authorities for its groundbreaking SARA-31 program. This initiative marks the first-ever phase 3 study targ. Read more
Breaking: Novartis Q2 Earnings Beat; Sarconeos Deal Boosts Biophytis
July 18th, 2023
Shares of Novartis AG (NYSE: NVS) experienced a surge in premarket trading as the company surpassed expectations in its second-quarter 2023 financial report. The pharmaceutical giant reported core earnings per share (EPS) of $1.83 and sales . Read more
Want To Find Some News?
News By Industries
Recent Post
-
FTC Takes Action to Prevent Anticompetitive Arrangement in Beretta, Ruger Deal
September 16th, 2026Why Opponent Preparation Matters for Post-Graduate Athletes
September 16th, 2026The Work Behind the Game: How Football Teams Prepare to Compete
September 15th, 2026NJCP Operates on a Prep Model Built Around a Full Season
September 14th, 2026Earnings Preview: High Tide, Kestra Medical, and RF Industries in Focus
September 12th, 2026
Member Login